Janux Therapeutics News

Janux Therapeutics Analyst Ratings

BenzingaMay 30 10:37 ET

Analysts Offer Insights on Healthcare Companies: Valneva (VALN), Janux Therapeutics Inc (JANX) and Kymera Therapeutics (KYMR)

TipRanksMay 13 09:45 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 13 07:18 ET

Buy Rating Affirmed for Janux Therapeutics With Revised Higher Price Target Amidst Strong Financials and Promising Clinical Trials

TipRanksMay 13 06:30 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 9 10:20 ET

Janux Therapeutics: Promising Early Data for EGFR-Targeted Therapies Warrants a Buy Rating

TipRanksMay 9 08:10 ET

Janux Therapeutics Analyst Ratings

BenzingaMay 8 10:44 ET

Wedbush Maintains Outperform on Janux Therapeutics, Raises Price Target to $74

BenzingaMay 8 10:44 ET

Janux Therapeutics Inc (JANX) Gets a Buy From Wedbush

TipRanksMay 8 08:41 ET

Janux Therapeutics Analyst Ratings

BenzingaApr 16 06:50 ET

Buy Rating Affirmed for Janux Therapeutics on Innovative Oncology Treatments and M&A Potential

TipRanksApr 15 16:20 ET

Analysts' Top Healthcare Picks: Humacyte (HUMA), Janux Therapeutics Inc (JANX)

TipRanksApr 10 21:15 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 21 06:01 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 20 05:24 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 13 10:32 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: MoonLake Immunotherapeutics (MLTX), Janux Therapeutics Inc (JANX) and SAGE Therapeutics (SAGE)

TipRanksMar 11 06:51 ET

Janux Therapeutics Analyst Ratings

BenzingaMar 11 06:27 ET

Janux Therapeutics Analyst Ratings

BenzingaFeb 27 08:54 ET

Buy Rating Affirmed for Janux Therapeutics on Strong Clinical Data and Advanced TRACTr Platform

TipRanksFeb 27 06:27 ET

Janux Therapeutics Analyst Ratings

BenzingaNov 13, 2023 10:43 ET